Journal article
The safety and efficacy of an oral penicillin challenge program in cancer patients: A multicenter pilot study
JA Trubiano, O Smibert, A Douglas, M Devchand, B Lambros, NE Holmes, KY Chua, EJ Phillips, MA Slavin
Open Forum Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2018
DOI: 10.1093/ofid/ofy306
Abstract
Antibiotic allergies are reported by up to 1 in 4 cancer patients, almost 50% of which are considered low risk and precede the cancer diagnosis. We demonstrate the successful and safe implementation of a pilot oral penicillin challenge program for cancer patients with low-risk penicillin allergies, increasing the use of penicillin and narrow-spectrum beta-lactams post-testing.
Related Projects (2)
Grants
Awarded by Peter MacCallum Cancer Centre
Funding Acknowledgements
J.A.T. is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (GNT 1139902) and a postgraduate scholarship from the National Centre for Infections in Cancer (NCIC), Peter MacCallum Cancer Centre (Melbourne, Australia). B.L. and M.A.S. are supported by an NHMRC Centres of Research Excellence grant (GNT 1116876). N.E.H. is supported by an NHMRC Early Careers Fellowship (GNT 1073378).